Based on an investigation by the College of Medicine Investigation Committee (the COMIC) at The Ohio State University, and JEM’s review, JEM is issuing this Expression of Concern regarding Figures 1 E and 1 F from Pichiorri et al. (2013) J. Exp. Med. 210(5):951–68 and Correction Pichiorri et al. (2017) J. Exp. Med. 214(5):1557.
Vol. 210, No. 5 | https://doi.org/10.1084/jem.20120950 | April 22, 2013
Vol. 214, No. 5 | https://doi.org/10.1084/jem.2012095001172017c | January 19, 2017
References
- Pichiorri Flavia, Palmieri Dario, De Luca Luciana, Consiglio Jessica, Jia You, Rocci Alberto, Talabere Tiffany, Piovan Claudia, Lagana Alessandro, Cascione Luciano, Guan Jingwen, Gasparini Pierluigi, Balatti Veronica, Nuovo Gerard, Coppola Vincenzo, Hofmeister Craig C., Guido Marcucci, Byrd John C., Volinia Stefano, Shapiro Charles L., Freitas Michael A., and Croce Carlo M.. 2013. J. Exp. Med. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 210:951–968. 10.1084/jem.20120950 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Pichiorri Flavia, Palmieri Dario, De Luca Luciana, Consiglio Jessica, Jia You, Rocci Alberto, Talabere Tiffany, Piovan Claudia, Lagana Alessandro, Cascione Luciano, Guan Jingwen, Gasparini Pierluigi, Balatti Veronica, Nuovo Gerard, Coppola Vincenzo, Hofmeister Craig C., Guido Marcucci, Byrd John C., Volinia Stefano, Shapiro Charles L., Freitas Michael A., and Croce Carlo M.. 2017. J. Exp. Med. Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 214:1557. 10.1084/jem.2012095001172017c [DOI] [PMC free article] [PubMed] [Google Scholar]